Recovering A Clinical Trial That Has Been Derailed
When your asset is on the line, your partner of choice matters more than ever....Continue reading→
Dawn Niccum Named CPR Chair-Elect, 2024
inSeption Group is thrilled to announce that Dawn Niccum has been designated as Chair-Elect of...Continue reading→
Entrepreneur of the Year
inSeption Group Co-Founders and Managing Partners Joe Arcangelo and Brian Sulpizio Named as EY Entrepreneurs...Continue reading→
Philadelphia Business Journal’s Fast 50 Growing Companies 2024
[Lansdale, PA] – [August 13th, 2024] – inSeption Group, a leading clinical outsourcing company, is proud...Continue reading→
Lori Buckenmyer
Meet our Executive Director, Clinical Operations and Project Management
Dawn Niccum
Meet our Executive Vice President, Quality Assurance
How To Build Effective Clinical Trial Oversight And Leadership
Sponsor-led oversight is critical in clinical trials, even when strategic input and operational tasks are...Continue reading→
High-Velocity Development: Gene Therapy Vs. Small Molecule
Gene therapy development operates at a high velocity compared to small molecule therapies, with parallel...Continue reading→
Jenny Minigh
Meet our Executive Vice President, Medical Writing
Rare Disease Clinical Endpoints: Ingenuity Meets Practicality
Discover why the science that brought you to this point can only take you so...Continue reading→
CRAs Must Evolve Alongside Oncology Therapeutics
Clinical Research Associates (CRAs) must adapt to the evolving demands of oncology therapeutics, which require...Continue reading→
Crissy Reynolds
Meet our Senior Director, Regulatory Operations
Raul P. Lima
Meet our Executive Vice President, Clinical Operations
Karin Rezzonico
Meet our Senior Director, Quality Assurance & Compliance
Our message to CMOs
For over 12 years, we’ve stood alongside the Chief Medical Officer Summit 360°, championing the...Continue reading→
FDA Update on ICH E6, E8, QbD and RBM in Clinical Trials
Integrating Quality by Design (QbD) and Risk-Based Monitoring (RBM) approaches in clinical trials enhances efficiency...Continue reading→
Revolutionizing Clinical Trials: The Power And Potential Of Risk-Based Monitoring
The article explores the benefits and misconceptions of risk-based monitoring (RBM) in clinical trials, emphasizing...Continue reading→
How Sponsors and Patients Benefit From a Site-Centric Partnership
Site-centric partnerships between sponsors and clinical trial sites can significantly enhance patient and personnel support,...Continue reading→
Is A Multitherapeutic Contract Research Partner The Best Fit For Your Clinical Trial?
Evaluating the suitability of multitherapeutic contract research organizations (CROs) for clinical trials is crucial, as...Continue reading→
Successful Regulatory Submission Via the Trifecta of Awesomeness
The article discusses the key elements that lead to a successful regulatory submission: strategic planning,...Continue reading→
Slow the Burn: How to Make Risk-Resilient Vendor Choices
Many pharmaceutical industry experts share similar principles for reducing financial risk when selecting an outsourcing...Continue reading→